Target audience
Respiratory clinicians, cardiology clinicians and trainees
Educational aims
Through a mix of lectures, workshops and case presentations, participants will learn to:
- Understand the diagnostic processes leading to a diagnosis of pulmonary hypertension/embolism
- Initiate appropriate investigations, understand the pathogenesis of the condition
- Understand the basis behind modern treatment of pulmonary hypertension and pulmonary thromboembolism
Programme
| |
Clinical features of pulmonary hypertension S. Gaine (Dublin, Ireland)
| |
Pathology of pulmonary hypertension P. Dorfmuller (Le Plessis Robinson, France)
| |
Pathobiology of pulmonary hypertension A. Peacock (Glasgow, United Kingdom)
| |
Pathophysiology of pulmonary hypertension R. Naeije (Beersel, Belgium)
| |
Right heart imaging and failure in pulmonary hypertension A. Vonk Noordegraaf (Amsterdam, Netherlands)
| |
Cardiac catheterisation lecture and video demonstration M. D'Alto (Naples, Italy)
| |
Radiology of pulmonary hypertension M. Sproule (Glasgow, United Kingdom)
| |
Exercise testing in pulmonary hypertension M. Johnson (Glasgow, United Kingdom)
| |
Making the diagnosis of acute pulmonary embolism S. Konstantinides (Mainz, Germany)
| |
Treatment of acute pulmonary embolism M. Johnson (Glasgow, United Kingdom)
| |
Diagnosis and treatment of chronic pulmonary embolism J. Pepke-Zaba (Cambridge, United Kingdom)
| |
Congenital heart disease and pulmonary hypertension (cardiology for pulmonologists) M. D'Alto (Naples, Italy)
| |
Exercise testing in pulmonary hypertension – live demonstration M. Johnson (Glasgow, United Kingdom)
| |
Current medical treatment of pulmonary arterial hypertension S. Gaine (Dublin, Ireland)
| |
Who to treat/who not to treat: Left heart disease R. Naeije (Beersel, Belgium)
| |
Who to treat/who not to treat: Hypoxic lung disease A. Vonk Noordegraaf (Amsterdam, Netherlands)
| |
Pulmonary hypertension in the intensive care unit B. Lamia (Rouen, France)
| |
Clinical trials in pulmonary arterial hypertension: what do they tell us R. Naeije (Beersel, Belgium)
| |
The future of treatment for pulmonary arterial hypertension A. Peacock (Glasgow, United Kingdom)
| |